MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
572.36%
Quick Ratio
572.36%
Cash Ratio
67.53%
Debt to Asset Ratio
12.12%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Long-term investments
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued contract manufacturing e...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
183,190
260,843
173,959
281,080
Short-term investments
1,303,648
1,476,335
1,387,000
1,430,240
Prepaid expenses and other current assets
65,830
76,310
66,402
55,847
Total current assets
1,552,668
1,813,488
1,627,361
1,767,167
Property and equipment, net
260,390
260,695
257,370
253,486
Operating lease right-of-use assets
110,178
113,103
116,009
83,515
Long-term investments
1,020,896
1,004,017
881,664
959,256
Restricted cash
1,465
1,466
1,466
1,468
Other assets
192,557
155,539
118,847
106,708
Total noncurrent assets
1,585,486
1,534,820
1,375,356
1,404,433
Total assets
3,138,154
3,348,308
3,002,717
3,171,600
Accounts payable
100,919
63,060
70,904
48,962
Accrued compensation
13,822
7,986
23,000
16,762
Accrued contract manufacturing expenses
125,298
134,704
74,654
103,959
Accrued expenses
24,728
30,247
31,068
24,592
Operating lease liabilities current
6,510
6,085
6,124
5,771
Total current liabilities
271,277
242,082
205,750
200,046
Operating lease liabilities long-term
108,935
110,212
111,357
78,672
Other liabilities
-
-
100
-
Total liabilities
380,212
352,294
317,207
278,718
Common stock, 0.001 par value 500,000,000 shares authorized at june30, 2026 and december31, 2025 144,785,934 and 131,058,858 shares issued and outstanding at june30, 2026 and december31, 2025, respectively
148
147
134
133
Additional paid-in capital
5,525,211
5,478,270
4,838,736
4,800,333
Accumulated other comprehensive (gain) loss
-7,546
-6,834
1,587
856
Accumulated deficit
-2,759,871
-2,475,569
-2,154,947
-1,908,440
Total stockholders' equity
2,757,942
2,996,014
2,685,510
2,892,882
Total liabilities and stockholders' equity
3,138,154
3,348,308
3,002,717
3,171,600
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Long-term investments$1,020,896K (-12.38%↓ Y/Y)Property and equipment,net$260,390K (7.48%↑ Y/Y)Other assets$192,557K (102.13%↑ Y/Y)Operating leaseright-of-use assets$110,178K (28.64%↑ Y/Y)Restricted cash$1,465K (11.07%↑ Y/Y)Short-term investments$1,303,648K (-3.77%↓ Y/Y)Cash and cashequivalents$183,190K (-40.28%↓ Y/Y)Prepaid expenses andother current assets$65,830K (21.13%↑ Y/Y)Total noncurrentassets$1,585,486K (-0.26%↓ Y/Y)Total current assets$1,552,668K (-9.51%↓ Y/Y)Total assets$3,138,154K (-5.06%↓ Y/Y)Total liabilities andstockholders' equity$3,138,154K (-5.06%↓ Y/Y)Total stockholders'equity$2,757,942K (-10.20%↓ Y/Y)Total liabilities$380,212K (62.46%↑ Y/Y)Accumulated deficit-$2,759,871K (-62.77%↓ Y/Y)Accumulated othercomprehensive (gain) loss-$7,546K (-299.89%↓ Y/Y)Additional paid-in capital$5,525,211K (15.86%↑ Y/Y)Total currentliabilities$271,277K (75.60%↑ Y/Y)Operating leaseliabilities long-term$108,935K (36.95%↑ Y/Y)Common stock, 0.001 parvalue 500,000,000...$148K (11.28%↑ Y/Y)Accrued contractmanufacturing expenses$125,298K (69.95%↑ Y/Y)Accounts payable$100,919K (221.25%↑ Y/Y)Accrued expenses$24,728K (-23.24%↓ Y/Y)Accrued compensation$13,822K (27.63%↑ Y/Y)Operating leaseliabilities current$6,510K (3.30%↑ Y/Y)

Vaxcyte, Inc. (PCVX)

Vaxcyte, Inc. (PCVX)